UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Outlook of IL-6 signaling blockade for COVID-19 pneumonia

Inflammation and Regeneration, 2020-10, Vol.40 (1), p.1-24, Article 24

Hashizume, Misato

2020

Volltextzugriff (PDF)

IL-6/IL-6 receptor system and its role in physiological and pathological conditions

Clinical science (1979), 2012-02, Vol.122 (4), p.143-159

2012

Volltextzugriff (PDF)

High molecular weight hyaluronic acid inhibits IL-6-induced MMP production from human chondrocytes by up-regulating the ERK inhibitor, MKP-1

Biochemical and biophysical research communications, 2010-12, Vol.403 (2), p.184-189

2010

Volltextzugriff (PDF)

The Roles of Interleukin-6 in the Pathogenesis of Rheumatoid Arthritis

Arthritis, 2011-01, Vol.2011 (2011), p.147-154

2011

Volltextzugriff (PDF)

Tocilizumab, a humanized anti-IL-6R antibody, as an emerging therapeutic option for rheumatoid arthritis: molecular and cellular mechanistic insights

International reviews of immunology, 2015-05, Vol.34 (3), p.265-279

2015

Volltextzugriff (PDF)

Tocilizumab, a Humanized Anti-interleukin-6 Receptor Antibody, Ameliorates Joint Swelling in Established Monkey Collagen-Induced Arthritis

Biological and Pharmaceutical Bulletin, 2008/06/01, Vol.31(6), pp.1159-1163

2008

Volltextzugriff (PDF)

Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule

Rheumatology international, 2010-01, Vol.30 (3), p.309-315

2010

Volltextzugriff (PDF)

Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate

Journal of translational medicine, 2018-06, Vol.16 (1), p.156-156, Article 156

2018

Volltextzugriff (PDF)

Induction of high-dose tolerance to the rat anti-mouse IL-6 receptor antibody in NZB/NZW F1 mice

Rheumatology international, 2011-11, Vol.31 (11), p.1445-1449

2011

Volltextzugriff (PDF)

Interleukin-6 regulates anti-arthritic effect of methotrexate via reduction of SLC19A1 expression in a mouse arthritis model

Arthritis research & therapy, 2012-04, Vol.14 (2), p.R96-R96, Article R96

2012

Volltextzugriff (PDF)

Striking Species Difference in the Contribution of Concentrative Nucleoside Transporter 2 to Nucleoside Uptake between Mouse and Rat Hepatocytes

Antimicrobial Agents and Chemotherapy, 2010-07, Vol.54 (7), p.3035-3038

2010

Volltextzugriff (PDF)

CS2C-2-4 IL-6 in autoimmune diseases

Journal of Pharmacological Sciences, 2014-02, Vol.124 (suppl), p.71-71

Misato Hashizume

2014

Volltextzugriff (PDF)

Peripheral blood CD4(+)CD25(+)CD127(low) regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response

Arthritis research & therapy, 2015-01, Vol.17, p.10-10

2015

Volltextzugriff (PDF)

IL-6 and lipid metabolism

Inflammation and Regeneration, 2011, Vol.31(3), pp.325-333

2011

Volltextzugriff (PDF)

Combination of High-Molecular-Weight Hyaluronic Acid and Cytokine Inhibitor Potently Inhibits Expression of Joint-Damage-Related Genes Induced By Synovial Fluid of RA Patients

Journal of arthritis, 2014, Vol.3 (1)

Hashizume, Misato

2014

Volltextzugriff (PDF)

IL-6 as a target in autoimmune disease and inflammation

Folia Pharmacologica Japonica, 2014, Vol.144(4), pp.172-177

2014

Volltextzugriff (PDF)

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production

Rheumatology international, 2010-05, Vol.30 (7), p.917-923

2010

Volltextzugriff (PDF)

IL-6/sIL-6R trans-signalling, but not TNF-α induced angiogenesis in a HUVEC and synovial cell co-culture system

Rheumatology international, 2009-10, Vol.29 (12), p.1449-1454

2009

Volltextzugriff (PDF)

IL-6 blockade preferentially inhibits Th17 differentiation in collagen-induced arthritis

Rheumatology international, 2011, Vol.31 (1), p.127-131

2011

Volltextzugriff (PDF)

Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling

Rheumatology international, 2009-02, Vol.29 (4), p.397-401

2009

Volltextzugriff (PDF)

Peripheral blood CD4+CD25+CD127low regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response

Arthritis research & therapy, 2015-01, Vol.17 (1), p.10-10, Article 10

2015

Volltextzugriff (PDF)

IL-6 and lipid metabolism

Inflammation and Regeneration, 2011, Vol.31 (3), p.325-333

2011

Volltextzugriff (PDF)

Host interleukin 6 production regulates inflammation but not tryptophan metabolism in the brain during murine GVHD

JCI insight, 2017-07, Vol.2 (14)

2017

Volltextzugriff (PDF)

IL-6/sIL-6R trans-signalling, but not TNF-[alpha] induced angiogenesis in a HUVEC and synovial cell co-culture system

Rheumatology international, 2009-10, Vol.29 (12), p.1449

2009

Volltextzugriff (PDF)

『IL-6 の多様な作用』　自己免疫性疾患および炎症性疾患における IL-6 の意義

日本薬理学雑誌, 2014, Vol.144(4), pp.172-177

2014

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Complete

Zeitschrift / SeriePlos One

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(27)

Sprache

Englisch
(23)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Humans
(11)
Animals
(9)
Rheumatology
(9)
Medicine
(7)
Medicine & Public Health
(7)
Tocilizumab
(7)
Interleukin-6
(6)
Interleukin-6 - Metabolism
(6)
Male
(6)
Receptors, Interleukin-6 - Immunology
(6)
Antibodies, Monoclonal - Pharmacology
(5)
Female
(5)
Mice
(5)
Antibodies, Monoclonal, Humanized
(4)
Cells, Cultured
(4)
Il-6
(4)
Immunology
(4)
Interleukin-6 - Antagonists & Inhibitors
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Outlook of IL-6 signaling blockade for COVID-19 pneumonia

IL-6/IL-6 receptor system and its role in physiological and pathological conditions

High molecular weight hyaluronic acid inhibits IL-6-induced MMP production from human chondrocytes by up-regulating the ERK inhibitor, MKP-1

The Roles of Interleukin-6 in the Pathogenesis of Rheumatoid Arthritis

Tocilizumab, a humanized anti-IL-6R antibody, as an emerging therapeutic option for rheumatoid arthritis: molecular and cellular mechanistic insights

Tocilizumab, a Humanized Anti-interleukin-6 Receptor Antibody, Ameliorates Joint Swelling in Established Monkey Collagen-Induced Arthritis

Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule

Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate

Induction of high-dose tolerance to the rat anti-mouse IL-6 receptor antibody in NZB/NZW F1 mice

Interleukin-6 regulates anti-arthritic effect of methotrexate via reduction of SLC19A1 expression in a mouse arthritis model

Striking Species Difference in the Contribution of Concentrative Nucleoside Transporter 2 to Nucleoside Uptake between Mouse and Rat Hepatocytes

CS2C-2-4 IL-6 in autoimmune diseases

Peripheral blood CD4(+)CD25(+)CD127(low) regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response

IL-6 and lipid metabolism

Combination of High-Molecular-Weight Hyaluronic Acid and Cytokine Inhibitor Potently Inhibits Expression of Joint-Damage-Related Genes Induced By Synovial Fluid of RA Patients

IL-6 as a target in autoimmune disease and inflammation

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production

IL-6/sIL-6R trans-signalling, but not TNF-α induced angiogenesis in a HUVEC and synovial cell co-culture system

IL-6 blockade preferentially inhibits Th17 differentiation in collagen-induced arthritis

Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling

Peripheral blood CD4+CD25+CD127low regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response

IL-6 and lipid metabolism

Host interleukin 6 production regulates inflammation but not tryptophan metabolism in the brain during murine GVHD

IL-6/sIL-6R trans-signalling, but not TNF-[alpha] induced angiogenesis in a HUVEC and synovial cell co-culture system

『IL-6 の多様な作用』　自己免疫性疾患および炎症性疾患における IL-6 の意義

Aktive Filter

Suchergebnisse filtern